Clinical reference Biomarker Directory
Back to directory

PRL

Established

Elevated prolactin suggests prolactinoma but more often reflects medication effects or a lab-interference artifact (macroprolactin).

Also known as Prolactin
In plain language

Prolactin is the hormone behind breastfeeding, and high levels outside pregnancy usually point to a pituitary tumor, a medication side effect, or an underactive thyroid. Sometimes, though, the test itself is misleadingly high because of a harmless antibody-bound form of the hormone — a lab quirk doctors now check for before assuming a tumor is present.

Biomarker & context

Prolactin (PRL) is a pituitary hormone primarily responsible for lactation; elevated levels outside of pregnancy/breastfeeding suggest either a prolactin-secreting pituitary tumor (prolactinoma) or another cause of hyperprolactinemia.

What it indicates

Elevated prolactin can indicate prolactinoma, but far more commonly results from medications (particularly antipsychotics), hypothyroidism, or pregnancy; a genuine lab-interference issue called macroprolactinemia (a larger, less bioactive antibody-bound form of prolactin) can also cause a falsely high result without any true pituitary pathology.

Diagnosis & clinical testing

Measured via serum immunoassay; labs increasingly screen for macroprolactin (via polyethylene glycol precipitation) before pursuing pituitary imaging for an isolated mild-to-moderate elevation, since a substantial fraction of unexplained elevations turn out to be macroprolactin, not true bioactive hormone excess.

Guiding treatment

Confirmed prolactinoma is typically treated first-line with dopamine agonist medications (cabergoline, bromocriptine), which shrink the tumor and normalize prolactin in most patients, reserving surgery for medication-resistant cases.

Clinical significance

Macroprolactin screening is now routine before pursuing pituitary imaging for an isolated elevation.

References
  1. General endocrinology reference literature on hyperprolactinemia workup and macroprolactin interference.